Cargando…
Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms
Human papillomavirus (HPV) causes cervical cancer and a large fraction of head and neck squamous cell carcinomas (HNSCC). Cidofovir (CDV) proved efficacious in the treatment of several HPV-induced benign and malignant hyper proliferations. To provide a better insight into how CDV selectively eradica...
Autores principales: | Mertens, Barbara, Nogueira, Tatiane, Stranska, Ruzena, Naesens, Lieve, Andrei, Graciela, Snoeck, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216943/ https://www.ncbi.nlm.nih.gov/pubmed/27331622 http://dx.doi.org/10.18632/oncotarget.10100 |
Ejemplares similares
-
Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage
por: De Schutter, Tim, et al.
Publicado: (2013) -
Investigation of tumor-tumor interactions in a double human cervical carcinoma xenograft model in nude mice
por: Mertens, Barbara, et al.
Publicado: (2018) -
Resistance to the nucleotide analogue cidofovir in HPV(+) cells: a multifactorial process involving UMP/CMP kinase 1
por: Topalis, Dimitri, et al.
Publicado: (2016) -
Cidofovir Activity against Poxvirus Infections
por: Andrei, Graciela, et al.
Publicado: (2010) -
New prodrugs of Adefovir and Cidofovir
por: Tichý, Tomáš, et al.
Publicado: (2011)